http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2216334-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff70c45647b8e87257cbe5a892168ba8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-18 |
| filingDate | 2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09329a6e36f1b87d09ea3c0e2313974e |
| publicationDate | 2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2216334-C1 |
| titleOfInvention | Saline solution |
| abstract | FIELD: medicine. SUBSTANCE: sodium chloride saline solution for injection prepared with apyrogenic water contains sodium chloride in the concentration 0.9%, potassium iodide and sodium or potassium bromide in the following ratio of components, wt.-%: sodium chloride, 0.9; potassium iodide, 1,5-2.5 x 10 -5 ; sodium or potassium bromide, 1.0-1.5 x 10 -3 ; apyrogenic water, the balance. Use of the solution allows to enhance activity of neutrophiles, monocytes and eosinophiles. EFFECT: valuable properties of solution. |
| priorityDate | 2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.